Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy.
Ohtsuka
Tomoaki
T
The Second Department of Internal Medicine, Ehime University School of Medicine, Shigenobu, Onsen-gun, Ehime, Japan.
Hamada
Mareomi
M
Saeki
Hideyuki
H
Ogimoto
Akiyoshi
A
Hiasa
G o
Go
Hara
Yuji
Y
Shigematsu
Yuji
Y
Hiwada
Kunio
K
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use*; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000378:metabolism; D000077261:Carvedilol; D016207:Cytokines / Q000097:blood / Q000187:drug effects*; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D008790:Metoprolol / Q000627:therapeutic use*; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D016207:Cytokines; D015850:Interleukin-6; D011412:Propanolamines; D014409:Tumor Necrosis Factor-alpha; D000077261:Carvedilol; D008790:Metoprolol